Novartis Posted August 10, 2026

Executive Director, Haematology, International Commercial Launch Strategy

Basel (City), Switzerland Regular
Commercial & General Management Executive/VP

Novartis is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

In this senior International CLS leadership role, you will help shape the global launch strategy for transformative treatment for blood cancers, driving impact across diverse markets and healthcare systems.

Executive Director, Haematology, International Commercial Launch Strategy #LI-HybridLocation: Basel, Switzerland  Welcome to where we thrive together!  Our aspiration at Novartis is to grow by ensuring every patient has access to the medicine they need as soon as possible.In this senior International CLS leadership role, you will help shape the global launch strategy for a transformative treatment in chronic myelogenous leukemia (CML), driving impact across diverse markets and healthcare systems.You will combine scientific insight, commercial expertise, and cross-functional partnership to support timely market entry and sustainable growth. Working closely with international and country teams, you will guide strategic decision-making, integrate market and customer insights, and encourage innovative approaches that expand patient access and strengthen leadership in haematology.This is an opportunity to influence the journey from development to commercialisation while enabling teams across regions to make a meaningful difference for people living with serious blood cancers.Key Responsibilities:Shape the international launch strategy for a leading CML treatment, ensuring alignment with haematology priorities and patient needs.Coordinate cross-functional collaboration across medical, regulatory, access, commercial, and supply teams to support effective execution.Enable launch readiness across priority markets by identifying risks early and supporting practical mitigation plans.Use market insights, competitive intelligence, and stakeholder feedback to refine global positioning and messaging.Partner with regional and country teams to support local execution while maintaining alignment with global strategy.Define, monitor, and govern critical launch milestones and performance indicators to support timely, evidence-based decisions.Communicate clearly with senior leaders on vision, progress, and strategic priorities across international markets.Promote strong standards of compliance, operational excellence, and best practice in launch execution.Contribute to development planning by helping shape target product profiles and evidence needs that support market access potential.Lead commercial excellence initiatives and strengthen customer-centred engagement approaches across regions.Essential requirements:Recent, significant Profit and Loss (P&L) leadership experience at country level.Approximately 15 years of progressive commercial experience across country and above‑country roles.Proven success leading launches and shaping therapeutic area strategy across diverse international markets.Strong understanding of hematology or related specialty areas, with experience translating scientific insights into strategic plans.Demonstrated ability to lead in complex, fast‑evolving environments and deliver results across high‑growth markets.Expertise in turning scientific data into differentiated value propositions across pre‑launch and lifecycle management phases.Consistent record of influencing cross‑unit and cross‑functional teams to achieve shared strategic goals.Ability to integrate multiple market insights and stakeholder perspectives to guide clear, evidence‑based decision‑making.Desirable Requirements:Proven ability to lead and inspire diverse, cross‑regional teams, fostering collaboration, clarity, and strategic alignment across complex environments.Demonstrated strength in influencing senior stakeholders and navigating matrixed structures to drive shared priorities and long‑term business impact.Benefits & RewardsAt Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen.Expected Annual Base Salary Range for role: 169,400.00 - 314,600.00 CHFThe base salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically.In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters.The rewards of being part of our team go far beyond base pay and incentives. We also offer a variety of competitive benefits in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs. In addition, we provide flexible and hybrid working options, where possible, and minimum 14 weeks paid parental leave.In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters. Long-term equity awards granted at group level may also be part of your package. Further details will be provided during the application process.Pay equity is a fundamental principle of our employment policy and reflects our commitment to create a diverse, equitable and inclusive environment that treats all employees with dignity and respect, as outlined in our Code of Ethics.Read our brochure to learn more about our global total rewards offering:https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdfNote: Benefits and compensation may vary by country and are subject to local legal requirements, including provisions of collective bargaining agreements where applicable. A full overview of your compensation package, including any relevant collective bargaining agreement details applicable to your role based on your employment location and Novartis employer entity, will be communicated separately to you during the application process.Commitment to Diversity and Inclusion Novartis is committed to building an outstanding, inclusive work environment and diverse teams’ representative of the patients and communities we serve.Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-cultureBenefits and Rewards: Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: https://www.novartis.com/careers/benefits-rewards

Job details

Seniority
Executive/VP
Function
Commercial & General Management
Therapeutic area
Not listed
Location
Basel (City), Switzerland
Employment type
Regular

How this role compares

Computed from every other active Commercial & General Management role in our database, not just this employer's listings.

We currently track 4 comparable Executive/VP Commercial & General Management roles across 2 biopharma companies.

4Comparable roles tracked
2Currently active
2Companies hiring similar roles
1Countries represented

Salary context

1 of 4 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject $169,400/yr – $314,600/yr
Only peer reporting · Senior Director, Corporate Responsibility Operations · Gilead Sciences, Inc. $243,100/yr – $314,600/yr
Peer group range $278,850 – $278,850 (median $278,850)

Where these roles are based

Top locations among the 4 comparable roles

United States4

Seniority mix

4 of 4 peers have a known seniority level

Senior Director3
Executive/VP1

Therapeutic area mix

1 of 4 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

45%similar
Gilead Sciences, Inc. Foster City, United States Executive/VP
Same function Same seniority
35%similar
Gilead Sciences, Inc. Foster City, United States Senior Director
Same function Adjacent seniority
35%similar
AstraZeneca Gaithersburg, Maryland, United States of America Senior Director
Same function Adjacent seniority
35%similar
AstraZeneca Gaithersburg, Maryland, United States of America Senior Director
Same function Adjacent seniority

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

45%
Senior Vice President, Chief Ethics & Compliance Office
Gilead Sciences, Inc. · Foster City, United States · Executive/VP
Function Therapeutic area Seniority Country
35%
Senior Director, Corporate Responsibility Operations
Gilead Sciences, Inc. · Foster City, United States · Senior Director
Function Therapeutic area Adjacent seniority Country
35%
Senior Director, Global Analytics & Insights
AstraZeneca · Gaithersburg, Maryland, United States of America · Senior Director
Function Therapeutic area Adjacent seniority Country
35%
Senior Director, Competitive Intelligence, Oncology R&D
AstraZeneca · Gaithersburg, Maryland, United States of America · Senior Director
Function Therapeutic area Adjacent seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.